Search clinical trials for: Keppra® Oral Solution

Total 56694 results

University of Cincinnati
Mayfield Clinic & Spine Institute

Completed

Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure Prevention (Keppra)

Traumatic Brain Injury | Subarachnoid Hemorrhage

United States
UCB Pharma

Completed

Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures

Epilepsy
UCB Pharma

Completed

A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy

Epilepsy
UCB Pharma

Completed

Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial Epilepsy

Epilepsy
UCB Pharma

Completed

S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy

Epilepsy
UCB Pharma

Completed

Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy

Epilepsy, Partial
UCB Pharma

Completed

A Safety and Efficacy Follow-up Study With Levetiracetam in Children (4-17 Years Old) Suffering From Absence Seizures

Absence Seizures
Calmy Alexandra

Recruiting

Immune Response of Shingrix Vaccine in People Living With HIV (> 50 y.o.) Compared to Age-matched Controls (Shingr'HIV)

RZV Vaccine (Shingrix ®)

Switzerland, France
UCB Pharma

Completed

Human Pharmacology Study (Keppra Dry Syrup Bioequivalence Study)

Healthy

United Kingdom
UCB Pharma

Completed

A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy

Epilepsy, Partial
University of Chicago

Active, not recruiting

Thirty Million Words Home Visiting (TMW HV RCT)

Language Environments of Children of Low-socioeconomic Status

United States
Pró Circulação®

Completed

Training-induced Muscle Strength and Its Role in Interface Pressure in Inelastic Compression

Resistance Training

Brazil
Croma-Pharma GmbH

Completed

Study to Evaluate the Effectiveness, Safety and Long Term Safety of Saypha® FILLER Lidocaine for Lip Augmentation (SayLip)

Abnormal Lip

Austria
Pró Circulação®

Recruiting

Non-elastic Compression Garment Therapy Versus Control for Deep Vein Thrombosis

Deep Vein Thrombosis | Post Thrombotic Syndrome

Brazil
Pró Circulação®

Recruiting

Vein Fitness System vs Compressive Therapy for Venous Ulcers: a Bayesian Adaptive Trial

Varicose Ulcer

Brazil
UCB Japan Co. Ltd.

Completed

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Epilepsy | Generalized Tonic-clonic Seizures

Japan
Imperial College London
Joint Replacement Instrumented Orthopaedics Ltd

Recruiting

Furlong Evolution® Hip Trial

Focus: A Multicentre Prospective Clinical Surveillance Study Aims to Assess the Clinical, Functional and Radiological Outcome of the Furlong Evolution® Hip Stem

United Kingdom
Children's Hospital Medical Center, Cincinnati

Completed

Dosing of Levetiracetam (Keppra) in Neonates

Seizures

United States
Stephanie Merhar, MD

Terminated

Efficacy of Keppra for Neonatal Seizures

Neonatal Seizures

United States
UCB Pharma

Completed

Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures

Epilepsy

United States, Poland, Mexico, Russian Federation
UCB Japan Co. Ltd.

Completed

An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy

Epilepsy | Partial Onset Seizures

Japan
Roxane Laboratories

Completed

Bioequivalency Study of Levetiracetam 1g Under Fasted Conditions

Seizures

United States
Roxane Laboratories

Completed

Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting Conditions

Seizures

United States
Peking Union Medical College Hospital
Beijing Chao Yang Hospital; Beijing Obstetrics and Gynecology Hospital; San MediTech(Huzhou)Co... and other collaborators

Unknown

Nutrition Product Combine With Continuous Glucose Monitoring in Gestational Diabetes Mellitus Patients

SANZ®KINGWILL Combined With CGM Equipment in GDM Patients | GLUCERNA SR® Combined With CGM Equipment in GDM Patients

China
UCB Pharma

Completed

Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures

Epilepsy, Partial

United States, France, United Kingdom, Germany, Belgium, Mexico, Poland, India, Romania, South Africa, Canada, Brazil, Russian Federation, Czech Republic, Hungary, Italy
University of Texas Southwestern Medical Center
UCB Pharma

Completed

Levetiracetam for Neuroprotection Against Corticosteroid-induced Hippocampal Dysfunction: A Proof of Concept Study

Memory Loss Associated With Corticosteroid Use | Manic State Associated With Corticosteroid Use

United States
Duke University
UCB Pharma

Completed

Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease

Motor Neuron Disease | Amyotrophic Lateral Sclerosis | Primary Lateral Sclerosis | Progressive Muscular Atrophy

United States
Tri-Service General Hospital

Completed

A Bioequivalence Study of Levetiracetam Versus Keppra

Healthy
UCB Pharma

Completed

Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam

Epilepsy

Spain
UCB Pharma

Completed

Bioequivalence Study of Levetiracetam Tablet and Intravenous Infusion in Healthy Japanese Subjects

Healthy Volunteers

United Kingdom
UCB Japan Co. Ltd.

Completed

Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method

Epilepsy, Partial
University of California, San Francisco
United States Department of Defense; University of California

Completed

Effects of Levetiracetam (Keppra) on Alcohol Consumption

Drug Abuse | Alcohol Abuse

United States
UCB Pharma

Completed

A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.

Epilepsy, Partial

United States, France, United Kingdom, Germany, Belgium, Mexico, Poland, Romania, Canada, Brazil, Russian Federation, Argentina, Hungary, Italy, Czechia
UCB Pharma
Parexel

Completed

Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients

Healthy Subjects | Renal Impairments

Japan
Children's Hospital Medical Center, Cincinnati

Completed

Pharmacokinetics of Levetiracetam (Keppra) in Neonates

Epilepsy | Seizures

United States
Yonsei University

Completed

The Effects on Cognitive Function of Levetiracetam (Keppra®) Compared to Carbamazepine (Tegretol®, Carmazepine®) as Monotherapy for Children With Partial Seizure; A Multicentric Randomized Controlled Study

Focal Epilepsy

Korea, Republic of
UCB Pharma

Completed

An Open-label, Bioequivalence Study to Evaluate LEV Administered as a 45-min Intravenous Infusion and Same Dosage LEV Oral Tablet in Chinese

Human Volunteers

China
Roxane Laboratories

Completed

Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fed Conditions

Seizures

United States
AMAG Pharmaceuticals, Inc.

Terminated

Study Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) When Administered Via Subcutaneous Auto-injector vs Intramuscular Injection Via Needle and Syringe in Healthy Post-menopausal Women

Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) in Healthy Post-menopausal Women

United States
University of South Florida

Withdrawn

Keppra IV for the Treatment of Motor Fluctuations in Parkinson's Disease

Parkinson's Disease

United States
Genomic Health®, Inc.

Terminated

Concordance of Key Actionable Genomic Alterations as Assessed in Tumor Tissue and Plasma in Non Small Cell Lung Cancer

Non Small Cell Lung Carcinoma

United States, Spain, Chile, France, Ireland, Japan, United Kingdom
UCB Pharma

Completed

Levetiracetam as add-on Treatment of Myoclonic Jerks in Adolescents + Adults

Generalized Convulsive Epilepsy
Vitamin Energy®
Citruslabs

Completed

A Clinical Trial to Assess the Effects of a Vitamin Shot on Energy Levels

Fatigue | Weight Loss | Mood | Cognition | Energy

United States
Genomic Health®, Inc.

Completed

Study In Urology Practices Looking At Impact Of OncotypeDX GPS Test On Men Choosing And Remaining On Active Surveillance

Prostate Cancer
Genomic Health®, Inc.

Completed

Validation of a Urine-based Assay With Genomic Markers for Predicting Recurrence for Non-muscle Invasive Bladder Cancer

Non-muscle Invasive Bladder Cancer

United States
National Cheng Kung University
National Cheng-Kung University Hospital; Ministry of Science and Technology...

Recruiting

Post-stroke Epilepsy: Primary Prophylaxis Study

Middle Cerebral Artery Stroke

Taiwan
UCB Japan Co. Ltd.

Completed

A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures

Epilepsies | Partial

Japan
UCB Pharma SA

Completed

Monotherapy With Levetiracetam in Patients Suffering From Epilepsy.

Epilepsy, Tonic-clonic

Poland, Sweden, Hungary, Czechia
UCB Pharma

Completed

Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.

Epilepsy, Tonic-clonic
University of California, San Francisco
UCB Pharma

Completed

Levetiracetam for Treatment of Pain Associated With Fibromyalgia

Fibromyalgia

United States

Search clinical trials for: Keppra® Oral Solution

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations